speb/financial-data huggingface dataset:
CTAS balance_sheet (quarterly, 2025-05-31) — Inventory: 1584769000.00
CTAS balance_sheet (annual, 2025-05-31) — Invested Capital: 7109480000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Invested Capital: 7109480000.00
CTAS cash_flow (annual, 2025-05-31) — Investing Cash Flow: -623638000.00
CTAS cash_flow (quarterly, 2025-05-31) — Investing Cash Flow: -149266000.00
CTAS balance_sheet (annual, 2025-05-31) — Investments And Advances: 339518000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Investments And Advances: 339518000.00
CTAS cash_flow (annual, 2025-05-31) — Issuance Of Debt: 398088000.00
CTAS balance_sheet (annual, 2025-05-31) — Land And Improvements: 195406000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Land And Improvements: 195406000.00
CTAS balance_sheet (annual, 2025-05-31) — Leases: 48463000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Leases: 48463000.00
CTAS balance_sheet (annual, 2025-05-31) — Long Term Capital Lease Obligation: 178738000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Long Term Capital Lease Obligation: 178738000.00
CTAS balance_sheet (annual, 2025-05-31) — Long Term Debt: 2424999000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Long Term Debt: 2424999000.00
CTAS balance_sheet (annual, 2025-05-31) — Long Term Debt And Capital Lease Obligation: 2603737000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Long Term Debt And Capital Lease Obligation: 2603737000.00
CTAS cash_flow (annual, 2025-05-31) — Long Term Debt Issuance: 398088000.00
CTAS cash_flow (annual, 2025-05-31) — Long Term Debt Payments: -450000000.00
CTAS cash_flow (quarterly, 2025-05-31) — Long Term Debt Payments: -450000000.00
CTAS cash_flow (annual, 2025-05-31) — Net Business Purchase And Sale: -232899000.00
CTAS cash_flow (quarterly, 2025-05-31) — Net Business Purchase And Sale: -34091000.00
CTAS cash_flow (annual, 2025-05-31) — Net Common Stock Issuance: -934800000.00
CTAS cash_flow (quarterly, 2025-05-31) — Net Common Stock Issuance: -256671000.00
CTAS balance_sheet (annual, 2025-05-31) — Net Debt: 2161026000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Net Debt: 2161026000.00
CTAS income_statement (annual, 2025-05-31) — Net Income: 1812281000.00
CTAS income_statement (quarterly, 2025-05-31) — Net Income: 448256000.00
CTAS income_statement (annual, 2025-05-31) — Net Income Common Stockholders: 1805930000.00
CTAS income_statement (quarterly, 2025-05-31) — Net Income Common Stockholders: 446696000.00
CTAS income_statement (annual, 2025-05-31) — Net Income Continuous Operations: 1812281000.00
CTAS income_statement (quarterly, 2025-05-31) — Net Income Continuous Operations: 448256000.00
CTAS income_statement (annual, 2025-05-31) — Net Income From Continuing And Discontinued Operation: 1812281000.00
CTAS income_statement (quarterly, 2025-05-31) — Net Income From Continuing And Discontinued Operation: 448256000.00
CTAS income_statement (annual, 2025-05-31) — Net Income From Continuing Operation Net Minority Interest: 1812281000.00
CTAS income_statement (quarterly, 2025-05-31) — Net Income From Continuing Operation Net Minority Interest: 448256000.00
CTAS cash_flow (annual, 2025-05-31) — Net Income From Continuing Operations: 1812281000.00
CTAS cash_flow (quarterly, 2025-05-31) — Net Income From Continuing Operations: 448256000.00
CTAS income_statement (annual, 2025-05-31) — Net Income Including Noncontrolling Interests: 1812281000.00
CTAS income_statement (quarterly, 2025-05-31) — Net Income Including Noncontrolling Interests: 448256000.00
CTAS income_statement (annual, 2025-05-31) — Net Interest Income: -95524000.00
CTAS income_statement (quarterly, 2025-05-31) — Net Interest Income: -22037000.00
CTAS cash_flow (annual, 2025-05-31) — Net Investment Purchase And Sale: -7196000.00
CTAS cash_flow (quarterly, 2025-05-31) — Net Investment Purchase And Sale: -132000.00
CTAS cash_flow (annual, 2025-05-31) — Net Issuance Payments Of Debt: -51912000.00
CTAS cash_flow (quarterly, 2025-05-31) — Net Issuance Payments Of Debt: -51912000.00
CTAS cash_flow (annual, 2025-05-31) — Net Long Term Debt Issuance: -51912000.00
CTAS cash_flow (quarterly, 2025-05-31) — Net Long Term Debt Issuance: -51912000.00
CTAS income_statement (annual, 2025-05-31) — Net Non Operating Interest Income Expense: -95524000.00
CTAS income_statement (quarterly, 2025-05-31) — Net Non Operating Interest Income Expense: -22037000.00
CTAS cash_flow (annual, 2025-05-31) — Net Other Financing Charges: -21568000.00
CTAS cash_flow (quarterly, 2025-05-31) — Net Other Financing Charges: -2120000.00
CTAS cash_flow (annual, 2025-05-31) — Net Other Investing Changes: 1369000.00
CTAS cash_flow (quarterly, 2025-05-31) — Net Other Investing Changes: -419000.00
CTAS balance_sheet (annual, 2025-05-31) — Net PPE: 1876857000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Net PPE: 1876857000.00
CTAS cash_flow (annual, 2025-05-31) — Net PPE Purchase And Sale: 23972000.00
CTAS cash_flow (quarterly, 2025-05-31) — Net PPE Purchase And Sale: 0.00
CTAS cash_flow (annual, 2025-05-31) — Net Short Term Debt Issuance: 0.00
CTAS balance_sheet (annual, 2025-05-31) — Net Tangible Assets: 974426000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Net Tangible Assets: 974426000.00
CTAS balance_sheet (annual, 2025-05-31) — Non Current Accrued Expenses: 420781000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Non Current Accrued Expenses: 420781000.00
CTAS balance_sheet (annual, 2025-05-31) — Non Current Deferred Assets: 275281000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Non Current Deferred Assets: 275281000.00
CTAS balance_sheet (annual, 2025-05-31) — Non Current Deferred Liabilities: 471740000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Non Current Deferred Liabilities: 471740000.00
CTAS balance_sheet (annual, 2025-05-31) — Non Current Deferred Taxes Liabilities: 471740000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Non Current Deferred Taxes Liabilities: 471740000.00
CTAS income_statement (annual, 2025-05-31) — Normalized EBITDA: 2859493000.00
CTAS income_statement (quarterly, 2025-05-31) — Normalized EBITDA: 721364000.00
CTAS income_statement (annual, 2025-05-31) — Normalized Income: 1812281000.00
CTAS income_statement (quarterly, 2025-05-31) — Normalized Income: 448256000.00
CTAS cash_flow (annual, 2025-05-31) — Operating Cash Flow: 2165905000.00
CTAS cash_flow (quarterly, 2025-05-31) — Operating Cash Flow: 635749000.00
CTAS cash_flow (annual, 2025-05-31) — Operating Gains Losses: -19341000.00
CTAS cash_flow (quarterly, 2025-05-31) — Operating Gains Losses: 0.00
CTAS income_statement (annual, 2025-05-31) — Operating Income: 2359726000.00
CTAS income_statement (quarterly, 2025-05-31) — Operating Income: 597452000.00
CTAS income_statement (annual, 2025-05-31) — Operating Revenue: 7976073000.00
CTAS income_statement (quarterly, 2025-05-31) — Operating Revenue: 2030680000.00
CTAS balance_sheet (annual, 2025-05-31) — Ordinary Shares Number: 402948000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Ordinary Shares Number: 402948000.00
CTAS balance_sheet (annual, 2025-05-31) — Other Current Assets: 170046000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Other Current Assets: 170046000.00
CTAS balance_sheet (annual, 2025-05-31) — Other Equity Adjustments: 84389000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Other Equity Adjustments: 84389000.00
CTAS balance_sheet (annual, 2025-05-31) — Other Intangible Assets: 309828000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Other Intangible Assets: 309828000.00
CTAS balance_sheet (annual, 2025-05-31) — Other Non Current Assets: 187361000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Other Non Current Assets: 187361000.00
CTAS balance_sheet (annual, 2025-05-31) — Other Properties: 3503976000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Other Properties: 3503976000.00
CTAS income_statement (annual, 2025-05-31) — Otherunder Preferred Stock Dividend: 6351000.00
CTAS income_statement (quarterly, 2025-05-31) — Otherunder Preferred Stock Dividend: 1560000.00
CTAS balance_sheet (annual, 2025-05-31) — Payables: 646909000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Payables: 646909000.00
CTAS balance_sheet (annual, 2025-05-31) — Payables And Accrued Expenses: 891310000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Payables And Accrued Expenses: 891310000.00
CTAS balance_sheet (annual, 2025-05-31) — Pensionand Other Post Retirement Benefit Plans Current: 438889000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Pensionand Other Post Retirement Benefit Plans Current: 438889000.00
CTAS balance_sheet (annual, 2025-05-31) — Preferred Stock: 0.00
CTAS balance_sheet (quarterly, 2025-05-31) — Preferred Stock: 0.00
CTAS income_statement (annual, 2025-05-31) — Pretax Income: 2264202000.00
CTAS income_statement (quarterly, 2025-05-31) — Pretax Income: 575415000.00
CTAS cash_flow (annual, 2025-05-31) — Proceeds From Stock Option Exercised: 896000.00
CTAS cash_flow (quarterly, 2025-05-31) — Proceeds From Stock Option Exercised: 197000.00
CTAS balance_sheet (annual, 2025-05-31) — Properties: 0.00
CTAS balance_sheet (quarterly, 2025-05-31) — Properties: 0.00
CTAS cash_flow (annual, 2025-05-31) — Purchase Of Business: -232899000.00
CTAS cash_flow (quarterly, 2025-05-31) — Purchase Of Business: -34091000.00
CTAS cash_flow (annual, 2025-05-31) — Purchase Of Investment: -7196000.00
CTAS cash_flow (quarterly, 2025-05-31) — Purchase Of Investment: -132000.00
CTAS balance_sheet (annual, 2025-05-31) — Raw Materials: 21763000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Raw Materials: 21763000.00
CTAS balance_sheet (annual, 2025-05-31) — Receivables: 1417381000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Receivables: 1417381000.00
CTAS income_statement (annual, 2025-05-31) — Reconciled Cost Of Revenue: 5166017000.00
CTAS income_statement (quarterly, 2025-05-31) — Reconciled Cost Of Revenue: 1341663000.00
CTAS income_statement (annual, 2025-05-31) — Reconciled Depreciation: 494183000.00
CTAS income_statement (quarterly, 2025-05-31) — Reconciled Depreciation: 121889000.00
CTAS cash_flow (annual, 2025-05-31) — Repayment Of Debt: -450000000.00
CTAS cash_flow (quarterly, 2025-05-31) — Repayment Of Debt: -450000000.00
CTAS cash_flow (annual, 2025-05-31) — Repurchase Of Capital Stock: -934800000.00
CTAS cash_flow (quarterly, 2025-05-31) — Repurchase Of Capital Stock: -256671000.00
CTAS balance_sheet (annual, 2025-05-31) — Retained Earnings: 11798451000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Retained Earnings: 11798451000.00
CTAS cash_flow (annual, 2025-05-31) — Sale Of PPE: 23972000.00
CTAS cash_flow (quarterly, 2025-05-31) — Sale Of PPE: 0.00
CTAS income_statement (annual, 2025-05-31) — Selling General And Administration: 2814438000.00
CTAS income_statement (quarterly, 2025-05-31) — Selling General And Administration: 728537000.00
CTAS balance_sheet (annual, 2025-05-31) — Share Issued: 776936000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Share Issued: 776936000.00
CTAS cash_flow (annual, 2025-05-31) — Stock Based Compensation: 128329000.00
CTAS cash_flow (quarterly, 2025-05-31) — Stock Based Compensation: 30743000.00
CTAS balance_sheet (annual, 2025-05-31) — Stockholders Equity: 4684481000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Stockholders Equity: 4684481000.00
CTAS balance_sheet (annual, 2025-05-31) — Tangible Book Value: 974426000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Tangible Book Value: 974426000.00
CTAS income_statement (annual, 2025-05-31) — Tax Effect Of Unusual Items: 0.00
CTAS income_statement (quarterly, 2025-05-31) — Tax Effect Of Unusual Items: 0.00
CTAS income_statement (annual, 2025-05-31) — Tax Provision: 451921000.00
CTAS income_statement (quarterly, 2025-05-31) — Tax Provision: 127159000.00
CTAS income_statement (annual, 2025-05-31) — Tax Rate For Calcs: 0.20
CTAS income_statement (quarterly, 2025-05-31) — Tax Rate For Calcs: 0.22
CTAS balance_sheet (annual, 2025-05-31) — Total Assets: 9825241000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Total Assets: 9825241000.00
CTAS balance_sheet (annual, 2025-05-31) — Total Capitalization: 7109480000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Total Capitalization: 7109480000.00
CTAS balance_sheet (annual, 2025-05-31) — Total Debt: 2654481000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Total Debt: 2654481000.00
CTAS balance_sheet (annual, 2025-05-31) — Total Equity Gross Minority Interest: 4684481000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Total Equity Gross Minority Interest: 4684481000.00
CTAS income_statement (annual, 2025-05-31) — Total Expenses: 7980455000.00
CTAS income_statement (quarterly, 2025-05-31) — Total Expenses: 2070200000.00
CTAS balance_sheet (annual, 2025-05-31) — Total Liabilities Net Minority Interest: 5140760000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Total Liabilities Net Minority Interest: 5140760000.00
CTAS balance_sheet (annual, 2025-05-31) — Total Non Current Assets: 6389072000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Total Non Current Assets: 6389072000.00
CTAS balance_sheet (annual, 2025-05-31) — Total Non Current Liabilities Net Minority Interest: 3496258000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Total Non Current Liabilities Net Minority Interest: 3496258000.00
CTAS income_statement (annual, 2025-05-31) — Total Operating Income As Reported: 2359726000.00
CTAS income_statement (quarterly, 2025-05-31) — Total Operating Income As Reported: 597452000.00
CTAS balance_sheet (annual, 2025-05-31) — Total Tax Payable: 4034000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Total Tax Payable: 4034000.00
CTAS balance_sheet (annual, 2025-05-31) — Treasury Shares Number: 373988000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Treasury Shares Number: 373988000.00
CTAS balance_sheet (annual, 2025-05-31) — Treasury Stock: 9791838000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Treasury Stock: 9791838000.00
CTAS balance_sheet (annual, 2025-05-31) — Work In Process: 42615000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Work In Process: 42615000.00
CTAS balance_sheet (annual, 2025-05-31) — Working Capital: 1791667000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Working Capital: 1791667000.00
CTAS income_statement (quarterly, 2025-08-31) — +Operating Expense: 748702000.00
CTAS income_statement (quarterly, 2025-08-31) — +Total Revenue: 2718122000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Accounts Payable: 462315000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Accounts Receivable: 1421047000.00
CTAS cash_flow (quarterly, 2025-08-31) — Amortization Cash Flow: 48348000.00
CTAS cash_flow (quarterly, 2025-08-31) — Amortization Of Intangibles: 48348000.00
CTAS income_statement (quarterly, 2025-08-31) — Basic Average Shares: 403292000.00
CTAS income_statement (quarterly, 2025-08-31) — Basic EPS: 1.21
CTAS cash_flow (quarterly, 2025-08-31) — Beginning Cash Position: 263973000.00
CTAS cash_flow (quarterly, 2025-08-31) — Capital Expenditure: -101957000.00
CTAS cash_flow (quarterly, 2025-08-31) — Capital Expenditure Reported: -101957000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Capital Lease Obligations: 249509000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Capital Stock: 2694077000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Cash And Cash Equivalents: 138143000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Cash Cash Equivalents And Short Term Investments: 138143000.00
CTAS cash_flow (quarterly, 2025-08-31) — Cash Dividends Paid: -157766000.00
CTAS cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Financing Activities: -424001000.00
CTAS cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Investing Activities: -116227000.00
CTAS cash_flow (quarterly, 2025-08-31) — Cash Flow From Continuing Operating Activities: 414481000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Account Payable: -22501000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Accrued Expense: -195389000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Income Tax Payable: 74625000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Inventory: -2398000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Other Current Assets: -34760000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Payable: 52124000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Payables And Accrued Expense: -143265000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Prepaid Assets: -62382000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Receivables: -3635000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Tax Payable: 74625000.00
CTAS cash_flow (quarterly, 2025-08-31) — Change In Working Capital: -246440000.00
CTAS cash_flow (quarterly, 2025-08-31) — Changes In Account Receivables: -3635000.00
CTAS cash_flow (quarterly, 2025-08-31) — Changes In Cash: -125747000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Common Stock: 2694077000.00
CTAS cash_flow (quarterly, 2025-08-31) — Common Stock Dividend Paid: -157766000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Common Stock Equity: 4755700000.00
CTAS cash_flow (quarterly, 2025-08-31) — Common Stock Payments: -266097000.00
CTAS income_statement (quarterly, 2025-08-31) — Cost Of Revenue: 1351561000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Current Accrued Expenses: 779672000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Current Assets: 3375926000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Current Capital Lease Obligation: 51691000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Current Debt And Capital Lease Obligation: 51691000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Current Liabilities: 1507819000.00
CTAS cash_flow (quarterly, 2025-08-31) — Deferred Income Tax: 13496000.00
CTAS cash_flow (quarterly, 2025-08-31) — Deferred Tax: 13496000.00
CTAS cash_flow (quarterly, 2025-08-31) — Depreciation: 77589000.00
CTAS cash_flow (quarterly, 2025-08-31) — Depreciation Amortization Depletion: 125937000.00
CTAS cash_flow (quarterly, 2025-08-31) — Depreciation And Amortization: 125937000.00
CTAS income_statement (quarterly, 2025-08-31) — Diluted Average Shares: 409294000.00
CTAS income_statement (quarterly, 2025-08-31) — Diluted EPS: 1.20
CTAS income_statement (quarterly, 2025-08-31) — Diluted NI Availto Com Stockholders: 489489000.00
CTAS income_statement (quarterly, 2025-08-31) — EBIT: 620068000.00
CTAS income_statement (quarterly, 2025-08-31) — EBITDA: 746005000.00
CTAS cash_flow (quarterly, 2025-08-31) — Effect Of Exchange Rate Changes: -83000.00
CTAS cash_flow (quarterly, 2025-08-31) — End Cash Position: 138143000.00
CTAS cash_flow (quarterly, 2025-08-31) — Financing Cash Flow: -424001000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Finished Goods: 1562736000.00
CTAS cash_flow (quarterly, 2025-08-31) — Free Cash Flow: 312524000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Gains Losses Not Affecting Retained Earnings: 79889000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Goodwill: 3410729000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Goodwill And Other Intangible Assets: 3708754000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Gross PPE: 1921088000.00
CTAS income_statement (quarterly, 2025-08-31) — Gross Profit: 1366561000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Income Tax Payable: 78956000.00
CTAS income_statement (quarterly, 2025-08-31) — Interest Expense: 24161000.00
CTAS income_statement (quarterly, 2025-08-31) — Interest Expense Non Operating: 24161000.00
CTAS income_statement (quarterly, 2025-08-31) — Interest Income: 2209000.00
CTAS income_statement (quarterly, 2025-08-31) — Interest Income Non Operating: 2209000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Inventory: 1622060000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Invested Capital: 7181457000.00
CTAS cash_flow (quarterly, 2025-08-31) — Investing Cash Flow: -116227000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Investments And Advances: 369503000.00
CTAS cash_flow (quarterly, 2025-08-31) — Issuance Of Debt: 0.00
CTAS balance_sheet (quarterly, 2025-08-31) — Long Term Capital Lease Obligation: 197818000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Long Term Debt: 2425757000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Long Term Debt And Capital Lease Obligation: 2623575000.00
CTAS cash_flow (quarterly, 2025-08-31) — Net Business Purchase And Sale: -7602000.00
CTAS cash_flow (quarterly, 2025-08-31) — Net Common Stock Issuance: -266097000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Net Debt: 2287614000.00
CTAS income_statement (quarterly, 2025-08-31) — Net Income: 491140000.00
CTAS income_statement (quarterly, 2025-08-31) — Net Income Common Stockholders: 489489000.00
CTAS income_statement (quarterly, 2025-08-31) — Net Income Continuous Operations: 491140000.00
CTAS income_statement (quarterly, 2025-08-31) — Net Income From Continuing And Discontinued Operation: 491140000.00
CTAS income_statement (quarterly, 2025-08-31) — Net Income From Continuing Operation Net Minority Interest: 491140000.00
CTAS cash_flow (quarterly, 2025-08-31) — Net Income From Continuing Operations: 491140000.00
CTAS income_statement (quarterly, 2025-08-31) — Net Income Including Noncontrolling Interests: 491140000.00
CTAS income_statement (quarterly, 2025-08-31) — Net Interest Income: -21952000.00
CTAS cash_flow (quarterly, 2025-08-31) — Net Investment Purchase And Sale: -6538000.00
CTAS cash_flow (quarterly, 2025-08-31) — Net Issuance Payments Of Debt: 0.00
CTAS income_statement (quarterly, 2025-08-31) — Net Non Operating Interest Income Expense: -21952000.00
CTAS cash_flow (quarterly, 2025-08-31) — Net Other Financing Charges: -2807000.00
CTAS cash_flow (quarterly, 2025-08-31) — Net Other Investing Changes: -130000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Net PPE: 1921088000.00
CTAS cash_flow (quarterly, 2025-08-31) — Net Short Term Debt Issuance: 0.00
CTAS balance_sheet (quarterly, 2025-08-31) — Net Tangible Assets: 1046946000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Non Current Accrued Expenses: 466153000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Non Current Deferred Assets: 283108000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Non Current Deferred Liabilities: 484443000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Non Current Deferred Taxes Liabilities: 484443000.00
CTAS income_statement (quarterly, 2025-08-31) — Normalized EBITDA: 746005000.00
CTAS income_statement (quarterly, 2025-08-31) — Normalized Income: 491140000.00
CTAS cash_flow (quarterly, 2025-08-31) — Operating Cash Flow: 414481000.00
CTAS income_statement (quarterly, 2025-08-31) — Operating Income: 617859000.00
CTAS income_statement (quarterly, 2025-08-31) — Operating Revenue: 2091066000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Ordinary Shares Number: 402950000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Other Current Assets: 194676000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Other Equity Adjustments: 79889000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Other Intangible Assets: 298025000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Other Non Current Assets: 179311000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Other Properties: 1921088000.00
CTAS income_statement (quarterly, 2025-08-31) — Otherunder Preferred Stock Dividend: 1651000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Payables: 541271000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Payables And Accrued Expenses: 1320943000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Pensionand Other Post Retirement Benefit Plans Current: 135185000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Preferred Stock: 0.00
CTAS income_statement (quarterly, 2025-08-31) — Pretax Income: 595907000.00
CTAS cash_flow (quarterly, 2025-08-31) — Proceeds From Stock Option Exercised: 2669000.00
CTAS cash_flow (quarterly, 2025-08-31) — Purchase Of Business: -7602000.00
CTAS cash_flow (quarterly, 2025-08-31) — Purchase Of Investment: -6538000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Raw Materials: 20007000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Receivables: 1421047000.00
CTAS income_statement (quarterly, 2025-08-31) — Reconciled Cost Of Revenue: 1351561000.00
CTAS income_statement (quarterly, 2025-08-31) — Reconciled Depreciation: 125937000.00
CTAS cash_flow (quarterly, 2025-08-31) — Repurchase Of Capital Stock: -266097000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Retained Earnings: 12107250000.00
CTAS income_statement (quarterly, 2025-08-31) — Selling General And Administration: 748702000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Share Issued: 778465000.00
CTAS cash_flow (quarterly, 2025-08-31) — Short Term Debt Issuance: 0.00
CTAS cash_flow (quarterly, 2025-08-31) — Stock Based Compensation: 30348000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Stockholders Equity: 4755700000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Tangible Book Value: 1046946000.00
CTAS income_statement (quarterly, 2025-08-31) — Tax Effect Of Unusual Items: 0.00
CTAS income_statement (quarterly, 2025-08-31) — Tax Provision: 104767000.00
CTAS income_statement (quarterly, 2025-08-31) — Tax Rate For Calcs: 0.18
CTAS balance_sheet (quarterly, 2025-08-31) — Total Assets: 9837690000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Total Capitalization: 7181457000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Total Debt: 2675266000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Total Equity Gross Minority Interest: 4755700000.00
CTAS income_statement (quarterly, 2025-08-31) — Total Expenses: 2100263000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Total Liabilities Net Minority Interest: 5081990000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Total Non Current Assets: 6461764000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Total Non Current Liabilities Net Minority Interest: 3574171000.00
CTAS income_statement (quarterly, 2025-08-31) — Total Operating Income As Reported: 617859000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Total Tax Payable: 78956000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Treasury Shares Number: 375515000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Treasury Stock: 10125516000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Work In Process: 39317000.00
CTAS balance_sheet (quarterly, 2025-08-31) — Working Capital: 1868107000.00
CTAS income_statement (quarterly, 2025-11-30) — +Operating Expense: 756771000.00
CTAS income_statement (quarterly, 2025-11-30) — +Total Revenue: 2799992000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Accounts Payable: 503273000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Accounts Receivable: 1484328000.00
CTAS cash_flow (quarterly, 2025-11-30) — Amortization Cash Flow: 48205000.00
CTAS cash_flow (quarterly, 2025-11-30) — Amortization Of Intangibles: 48205000.00
CTAS income_statement (quarterly, 2025-11-30) — Basic Average Shares: 401484000.00
CTAS income_statement (quarterly, 2025-11-30) — Basic EPS: 1.23
CTAS cash_flow (quarterly, 2025-11-30) — Beginning Cash Position: 138143000.00
CTAS cash_flow (quarterly, 2025-11-30) — Capital Expenditure: -106252000.00
CTAS cash_flow (quarterly, 2025-11-30) — Capital Expenditure Reported: -106252000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Capital Lease Obligations: 259786000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Capital Stock: 2743927000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 200842000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 200842000.00
CTAS cash_flow (quarterly, 2025-11-30) — Cash Dividends Paid: -182343000.00
CTAS cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Financing Activities: -275011000.00
CTAS cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Investing Activities: -192854000.00
CTAS cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Operating Activities: 531223000.00
CTAS cash_flow (quarterly, 2025-11-30) — Change In Account Payable: 41861000.00
CTAS cash_flow (quarterly, 2025-11-30) — Change In Accrued Expense: 43615000.00
CTAS cash_flow (quarterly, 2025-11-30) — Change In Inventory: 1679000.00
CTAS cash_flow (quarterly, 2025-11-30) — Change In Other Current Assets: -42041000.00
CTAS cash_flow (quarterly, 2025-11-30) — Change In Payable: -32764000.00
CTAS cash_flow (quarterly, 2025-11-30) — Change In Payables And Accrued Expense: 10851000.00
CTAS cash_flow (quarterly, 2025-11-30) — Change In Prepaid Assets: -41320000.00
CTAS cash_flow (quarterly, 2025-11-30) — Change In Receivables: -64704000.00
CTAS cash_flow (quarterly, 2025-11-30) — Change In Working Capital: -136123000.00
CTAS cash_flow (quarterly, 2025-11-30) — Changes In Account Receivables: -64704000.00
CTAS cash_flow (quarterly, 2025-11-30) — Changes In Cash: 63358000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Commercial Paper: 550750000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Common Stock: 2743927000.00
CTAS cash_flow (quarterly, 2025-11-30) — Common Stock Dividend Paid: -182343000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 4455347000.00
CTAS cash_flow (quarterly, 2025-11-30) — Common Stock Payments: -635570000.00
CTAS income_statement (quarterly, 2025-11-30) — Cost Of Revenue: 1387507000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Current Accrued Expenses: 797710000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Current Assets: 3540088000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Current Capital Lease Obligation: 52726000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Current Debt: 550750000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Current Debt And Capital Lease Obligation: 603476000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Current Liabilities: 2075985000.00
CTAS cash_flow (quarterly, 2025-11-30) — Deferred Income Tax: 12149000.00
CTAS cash_flow (quarterly, 2025-11-30) — Deferred Tax: 12149000.00
CTAS cash_flow (quarterly, 2025-11-30) — Depreciation: 79296000.00
CTAS cash_flow (quarterly, 2025-11-30) — Depreciation Amortization Depletion: 127501000.00
CTAS cash_flow (quarterly, 2025-11-30) — Depreciation And Amortization: 127501000.00
CTAS income_statement (quarterly, 2025-11-30) — Diluted Average Shares: 406433000.00
CTAS income_statement (quarterly, 2025-11-30) — Diluted EPS: 1.21
CTAS income_statement (quarterly, 2025-11-30) — Diluted NI Availto Com Stockholders: 493737000.00
CTAS income_statement (quarterly, 2025-11-30) — EBIT: 656580000.00
CTAS income_statement (quarterly, 2025-11-30) — EBITDA: 784081000.00
CTAS cash_flow (quarterly, 2025-11-30) — Effect Of Exchange Rate Changes: -659000.00
CTAS cash_flow (quarterly, 2025-11-30) — End Cash Position: 200842000.00
CTAS cash_flow (quarterly, 2025-11-30) — Financing Cash Flow: -275011000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Finished Goods: 1599708000.00
CTAS cash_flow (quarterly, 2025-11-30) — Free Cash Flow: 424971000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Gains Losses Not Affecting Retained Earnings: 67726000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Goodwill: 3483504000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Goodwill And Other Intangible Assets: 3781233000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Gross PPE: 1956951000.00
CTAS income_statement (quarterly, 2025-11-30) — Gross Profit: 1412485000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Income Tax Payable: 3654000.00
CTAS income_statement (quarterly, 2025-11-30) — Interest Expense: 28076000.00
CTAS income_statement (quarterly, 2025-11-30) — Interest Expense Non Operating: 28076000.00
CTAS income_statement (quarterly, 2025-11-30) — Interest Income: 866000.00
CTAS income_statement (quarterly, 2025-11-30) — Interest Income Non Operating: 866000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Inventory: 1661110000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Invested Capital: 7432626000.00
CTAS cash_flow (quarterly, 2025-11-30) — Investing Cash Flow: -192854000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Investments And Advances: 386281000.00
CTAS cash_flow (quarterly, 2025-11-30) — Issuance Of Debt: 550750000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Long Term Capital Lease Obligation: 207060000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Long Term Debt: 2426529000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Long Term Debt And Capital Lease Obligation: 2633589000.00
CTAS cash_flow (quarterly, 2025-11-30) — Net Business Purchase And Sale: -85634000.00
CTAS cash_flow (quarterly, 2025-11-30) — Net Common Stock Issuance: -635570000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Net Debt: 2776437000.00
CTAS income_statement (quarterly, 2025-11-30) — Net Income: 495343000.00
CTAS income_statement (quarterly, 2025-11-30) — Net Income Common Stockholders: 493737000.00
CTAS income_statement (quarterly, 2025-11-30) — Net Income Continuous Operations: 495343000.00
CTAS income_statement (quarterly, 2025-11-30) — Net Income From Continuing And Discontinued Operation: 495343000.00
CTAS income_statement (quarterly, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: 495343000.00
CTAS cash_flow (quarterly, 2025-11-30) — Net Income From Continuing Operations: 495343000.00
CTAS income_statement (quarterly, 2025-11-30) — Net Income Including Noncontrolling Interests: 495343000.00
CTAS income_statement (quarterly, 2025-11-30) — Net Interest Income: -27210000.00
CTAS cash_flow (quarterly, 2025-11-30) — Net Investment Purchase And Sale: 32000.00
CTAS cash_flow (quarterly, 2025-11-30) — Net Issuance Payments Of Debt: 550750000.00
CTAS income_statement (quarterly, 2025-11-30) — Net Non Operating Interest Income Expense: -27210000.00
CTAS cash_flow (quarterly, 2025-11-30) — Net Other Financing Charges: -8275000.00
CTAS cash_flow (quarterly, 2025-11-30) — Net Other Investing Changes: -1000000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Net PPE: 1956951000.00
CTAS cash_flow (quarterly, 2025-11-30) — Net Short Term Debt Issuance: 550750000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 674114000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Non Current Accrued Expenses: 472619000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Non Current Deferred Assets: 290913000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Non Current Deferred Liabilities: 495341000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Non Current Deferred Taxes Liabilities: 495341000.00
CTAS income_statement (quarterly, 2025-11-30) — Normalized EBITDA: 784081000.00
CTAS income_statement (quarterly, 2025-11-30) — Normalized Income: 495343000.00
CTAS cash_flow (quarterly, 2025-11-30) — Operating Cash Flow: 531223000.00
CTAS income_statement (quarterly, 2025-11-30) — Operating Income: 655714000.00
CTAS income_statement (quarterly, 2025-11-30) — Operating Revenue: 2155400000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 399889646.00
CTAS balance_sheet (quarterly, 2025-11-30) — Other Current Assets: 193808000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Other Equity Adjustments: 67726000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Other Intangible Assets: 297729000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Other Non Current Assets: 177415000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Other Properties: 1956951000.00
CTAS income_statement (quarterly, 2025-11-30) — Otherunder Preferred Stock Dividend: 1606000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Payables: 506927000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Payables And Accrued Expenses: 1304637000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Pensionand Other Post Retirement Benefit Plans Current: 167872000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Preferred Stock: 0.00
CTAS income_statement (quarterly, 2025-11-30) — Pretax Income: 628504000.00
CTAS cash_flow (quarterly, 2025-11-30) — Proceeds From Stock Option Exercised: 427000.00
CTAS cash_flow (quarterly, 2025-11-30) — Purchase Of Business: -85634000.00
CTAS cash_flow (quarterly, 2025-11-30) — Purchase Of Investment: 32000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Raw Materials: 18708000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Receivables: 1484328000.00
CTAS income_statement (quarterly, 2025-11-30) — Reconciled Cost Of Revenue: 1387507000.00
CTAS income_statement (quarterly, 2025-11-30) — Reconciled Depreciation: 127501000.00
CTAS cash_flow (quarterly, 2025-11-30) — Repurchase Of Capital Stock: -635570000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Retained Earnings: 12421850000.00
CTAS income_statement (quarterly, 2025-11-30) — Selling General And Administration: 756771000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Share Issued: 778819646.00
CTAS cash_flow (quarterly, 2025-11-30) — Short Term Debt Issuance: 550750000.00
CTAS cash_flow (quarterly, 2025-11-30) — Stock Based Compensation: 32353000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 4455347000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 674114000.00
CTAS income_statement (quarterly, 2025-11-30) — Tax Effect Of Unusual Items: 0.00
CTAS income_statement (quarterly, 2025-11-30) — Tax Provision: 133161000.00
CTAS income_statement (quarterly, 2025-11-30) — Tax Rate For Calcs: 0.21
CTAS balance_sheet (quarterly, 2025-11-30) — Total Assets: 10132881000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Total Capitalization: 6881876000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Total Debt: 3237065000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 4455347000.00
CTAS income_statement (quarterly, 2025-11-30) — Total Expenses: 2144278000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 5677534000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Total Non Current Assets: 6592793000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 3601549000.00
CTAS income_statement (quarterly, 2025-11-30) — Total Operating Income As Reported: 655714000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Total Tax Payable: 3654000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Treasury Shares Number: 378930000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Treasury Stock: 10778156000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Work In Process: 42694000.00
CTAS balance_sheet (quarterly, 2025-11-30) — Working Capital: 1464103000.00
CTAS income_statement (quarterly, 2026-02-28) — +Operating Expense: 788552000.00
CTAS income_statement (quarterly, 2026-02-28) — +Total Revenue: 2841444000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Accounts Payable: 481010000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Accounts Receivable: 1542973000.00
CTAS cash_flow (quarterly, 2026-02-28) — Amortization Cash Flow: 48521000.00
CTAS cash_flow (quarterly, 2026-02-28) — Amortization Of Intangibles: 48521000.00
CTAS income_statement (quarterly, 2026-02-28) — Basic Average Shares: 400040000.00
CTAS income_statement (quarterly, 2026-02-28) — Basic EPS: 1.25
CTAS cash_flow (quarterly, 2026-02-28) — Beginning Cash Position: 200842000.00
CTAS cash_flow (quarterly, 2026-02-28) — Capital Expenditure: -90898000.00
CTAS cash_flow (quarterly, 2026-02-28) — Capital Expenditure Reported: -90898000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Capital Lease Obligations: 261396000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Capital Stock: 2807548000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Cash And Cash Equivalents: 183204000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Cash Cash Equivalents And Short Term Investments: 183204000.00
CTAS cash_flow (quarterly, 2026-02-28) — Cash Dividends Paid: -180741000.00
CTAS cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Financing Activities: -539961000.00
CTAS cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Investing Activities: -101070000.00
CTAS cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Operating Activities: 621472000.00
CTAS cash_flow (quarterly, 2026-02-28) — Change In Account Payable: -23573000.00
CTAS cash_flow (quarterly, 2026-02-28) — Change In Accrued Expense: 79249000.00
CTAS cash_flow (quarterly, 2026-02-28) — Change In Inventory: -2694000.00
CTAS cash_flow (quarterly, 2026-02-28) — Change In Other Current Assets: -25060000.00
CTAS cash_flow (quarterly, 2026-02-28) — Change In Other Working Capital: 6788000.00
CTAS cash_flow (quarterly, 2026-02-28) — Change In Payable: -23573000.00
CTAS cash_flow (quarterly, 2026-02-28) — Change In Payables And Accrued Expense: 55676000.00
CTAS cash_flow (quarterly, 2026-02-28) — Change In Prepaid Assets: -34489000.00
CTAS cash_flow (quarterly, 2026-02-28) — Change In Receivables: -56459000.00
CTAS cash_flow (quarterly, 2026-02-28) — Change In Working Capital: -56238000.00
CTAS cash_flow (quarterly, 2026-02-28) — Changes In Account Receivables: -56459000.00
CTAS cash_flow (quarterly, 2026-02-28) — Changes In Cash: -19559000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Commercial Paper: 229490000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Common Stock: 2807548000.00
CTAS cash_flow (quarterly, 2026-02-28) — Common Stock Dividend Paid: -180741000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Common Stock Equity: 4788383000.00
CTAS cash_flow (quarterly, 2026-02-28) — Common Stock Payments: -31560000.00
CTAS income_statement (quarterly, 2026-02-28) — Cost Of Revenue: 1392988000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Current Accrued Expenses: 831037000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Current Assets: 3602934000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Current Capital Lease Obligation: 54130000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Current Debt: 229490000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Current Debt And Capital Lease Obligation: 283620000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Current Liabilities: 1816902000.00
CTAS cash_flow (quarterly, 2026-02-28) — Deferred Income Tax: 12295000.00
CTAS cash_flow (quarterly, 2026-02-28) — Deferred Tax: 12295000.00
CTAS cash_flow (quarterly, 2026-02-28) — Depreciation: 80149000.00
CTAS cash_flow (quarterly, 2026-02-28) — Depreciation Amortization Depletion: 128670000.00
CTAS cash_flow (quarterly, 2026-02-28) — Depreciation And Amortization: 128670000.00
CTAS income_statement (quarterly, 2026-02-28) — Diluted Average Shares: 404717000.00
CTAS income_statement (quarterly, 2026-02-28) — Diluted EPS: 1.24
CTAS income_statement (quarterly, 2026-02-28) — Diluted NI Availto Com Stockholders: 500899000.00
CTAS income_statement (quarterly, 2026-02-28) — EBIT: 660709000.00
CTAS income_statement (quarterly, 2026-02-28) — EBITDA: 789379000.00
CTAS cash_flow (quarterly, 2026-02-28) — Effect Of Exchange Rate Changes: 1921000.00
CTAS cash_flow (quarterly, 2026-02-28) — End Cash Position: 183204000.00
CTAS cash_flow (quarterly, 2026-02-28) — Financing Cash Flow: -539961000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Finished Goods: 1626097000.00
CTAS cash_flow (quarterly, 2026-02-28) — Free Cash Flow: 530574000.00
CTAS cash_flow (quarterly, 2026-02-28) — Gain Loss On Sale Of PPE: 0.00
CTAS balance_sheet (quarterly, 2026-02-28) — Gains Losses Not Affecting Retained Earnings: 76153000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Goodwill: 3499028000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Goodwill And Other Intangible Assets: 3785774000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Gross PPE: 1972154000.00
CTAS income_statement (quarterly, 2026-02-28) — Gross Profit: 1448456000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Income Tax Payable: 11240000.00
CTAS income_statement (quarterly, 2026-02-28) — Interest Expense: 28212000.00
CTAS income_statement (quarterly, 2026-02-28) — Interest Expense Non Operating: 28212000.00
CTAS income_statement (quarterly, 2026-02-28) — Interest Income: 805000.00
CTAS income_statement (quarterly, 2026-02-28) — Interest Income Non Operating: 805000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Inventory: 1691149000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Invested Capital: 7445174000.00
CTAS cash_flow (quarterly, 2026-02-28) — Investing Cash Flow: -101070000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Investments And Advances: 407138000.00
CTAS cash_flow (quarterly, 2026-02-28) — Issuance Of Debt: -321260000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Long Term Capital Lease Obligation: 207266000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Long Term Debt: 2427301000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Long Term Debt And Capital Lease Obligation: 2634567000.00
CTAS cash_flow (quarterly, 2026-02-28) — Net Business Purchase And Sale: -9449000.00
CTAS cash_flow (quarterly, 2026-02-28) — Net Common Stock Issuance: -31560000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Net Debt: 2473587000.00
CTAS income_statement (quarterly, 2026-02-28) — Net Income: 502496000.00
CTAS income_statement (quarterly, 2026-02-28) — Net Income Common Stockholders: 500899000.00
CTAS income_statement (quarterly, 2026-02-28) — Net Income Continuous Operations: 502496000.00
CTAS income_statement (quarterly, 2026-02-28) — Net Income From Continuing And Discontinued Operation: 502496000.00
CTAS income_statement (quarterly, 2026-02-28) — Net Income From Continuing Operation Net Minority Interest: 502496000.00
CTAS cash_flow (quarterly, 2026-02-28) — Net Income From Continuing Operations: 502496000.00
CTAS income_statement (quarterly, 2026-02-28) — Net Income Including Noncontrolling Interests: 502496000.00
CTAS income_statement (quarterly, 2026-02-28) — Net Interest Income: -27407000.00
CTAS cash_flow (quarterly, 2026-02-28) — Net Investment Purchase And Sale: -1765000.00
CTAS cash_flow (quarterly, 2026-02-28) — Net Issuance Payments Of Debt: -321260000.00
CTAS income_statement (quarterly, 2026-02-28) — Net Non Operating Interest Income Expense: -27407000.00
CTAS cash_flow (quarterly, 2026-02-28) — Net Other Financing Charges: -6460000.00
CTAS cash_flow (quarterly, 2026-02-28) — Net Other Investing Changes: 1042000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Net PPE: 1972154000.00
CTAS cash_flow (quarterly, 2026-02-28) — Net PPE Purchase And Sale: 0.00
CTAS cash_flow (quarterly, 2026-02-28) — Net Short Term Debt Issuance: -321260000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Net Tangible Assets: 1002609000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Non Current Accrued Expenses: 486261000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Assets: 296495000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Liabilities: 507608000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Taxes Liabilities: 507608000.00
CTAS income_statement (quarterly, 2026-02-28) — Normalized EBITDA: 789379000.00
CTAS income_statement (quarterly, 2026-02-28) — Normalized Income: 502496000.00
CTAS cash_flow (quarterly, 2026-02-28) — Operating Cash Flow: 621472000.00
CTAS income_statement (quarterly, 2026-02-28) — Operating Income: 659904000.00
CTAS income_statement (quarterly, 2026-02-28) — Operating Revenue: 2177453000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Ordinary Shares Number: 400015000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Other Current Assets: 185608000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Other Equity Adjustments: 76153000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Other Intangible Assets: 286746000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Other Non Current Assets: 169226000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Other Properties: 1972154000.00
CTAS income_statement (quarterly, 2026-02-28) — Otherunder Preferred Stock Dividend: 1597000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Payables: 492250000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Payables And Accrued Expenses: 1323287000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Pensionand Other Post Retirement Benefit Plans Current: 209995000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Preferred Stock: 0.00
CTAS income_statement (quarterly, 2026-02-28) — Pretax Income: 632497000.00
CTAS cash_flow (quarterly, 2026-02-28) — Proceeds From Stock Option Exercised: 60000.00
CTAS cash_flow (quarterly, 2026-02-28) — Purchase Of Business: -9449000.00
CTAS cash_flow (quarterly, 2026-02-28) — Purchase Of Investment: -1765000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Raw Materials: 18553000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Receivables: 1542973000.00
CTAS income_statement (quarterly, 2026-02-28) — Reconciled Cost Of Revenue: 1392988000.00
CTAS income_statement (quarterly, 2026-02-28) — Reconciled Depreciation: 128670000.00
CTAS cash_flow (quarterly, 2026-02-28) — Repurchase Of Capital Stock: -31560000.00
CTAS balance_sheet (quarterly, 2026-02-28) — Retained Earnings: 12743710000.00
CTAS cash_flow (quarterly, 2026-02-28) — Sale Of PPE: 0.00